In summary, the activation of the TNFR2 signaling pathway seems to negatively influence the effective CD8+ T cells priming, movement, chemoattraction, survival, and stimulation of dendritic cells in the BC TME. The gene discussed is TNFRSF1B; the disease is breast cancer.